Literature DB >> 24849155

Letter: comparative efficacy of biological therapy in patients with ulcerative colitis.

S Singh1, S K Garg, Z Wang, M H Murad, E V Loftus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24849155     DOI： 10.1111/apt.12760

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  3 in total

1.  Comparison of Infliximab and Adalimumab in Biologic-Naive Patients With Ulcerative Colitis: A Nationwide Danish Cohort Study.

Authors:  Siddharth Singh; Nynne Nyboe Andersen; Mikael Andersson; Edward V Loftus; Tine Jess
Journal:  Clin Gastroenterol Hepatol       Date:  2016-11-29       Impact factor: 11.382

2.  Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis.

Authors:  S Singh; H C Heien; L R Sangaralingham; S R Schilz; M D Kappelman; N D Shah; E V Loftus
Journal:  Aliment Pharmacol Ther       Date:  2016-03-15       Impact factor: 8.171

Review 3.  Golimumab for the treatment of ulcerative colitis.

Authors:  Mathurin Flamant; Stephane Paul; Xavier Roblin
Journal:  Expert Opin Biol Ther       Date:  2017-05-16       Impact factor: 4.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.